000			01947 a2200445 4500
005			20250513090929.0
264		0	_c19960709
008			199607s 0 0 eng d
022			_a0732-183X
024	7		_a10.1200/JCO.1996.14.2.479 _2doi
040			_aNLM _beng _cNLM
100	1		_aFraker, D L
245	0	0	_aTreatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation study. _h[electronic resource]
260			_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cFeb 1996
300			_a479-89 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Agents, Alkylating _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aChemotherapy, Cancer, Regional Perfusion
650	0	4	_aExtremities
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInterferon-gamma _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMelanoma _xtherapy
650	0	4	_aMelphalan _xadministration & dosage
650	0	4	_aMiddle Aged
650	0	4	_aRecombinant Proteins _xadministration & dosage
650	0	4	_aSoft Tissue Neoplasms _xtherapy
650	0	4	_aTreatment Outcome
650	0	4	_aTumor Necrosis Factor-alpha _xadministration & dosage
700	1		_aAlexander, H R
700	1		_aAndrich, M
700	1		_aRosenberg, S A
773	0		_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 14 _gno. 2 _gp. 479-89
856	4	0	_uhttps://doi.org/10.1200/JCO.1996.14.2.479 _zAvailable from publisher's website
999			_c8635801 _d8635801